Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 2/2002

Content (12 Articles)

Original Article

An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics

Eric E. Nilsson, Suzanne D. Westfall, Claudia McDonald, Tiffany Lison, Ingrid Sadler-Riggleman, Michael K. Skinner

Original Article

The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase

Jeanne Fourie, Curtis J. Oleschuk, Frank Guziec, Lynn Guziec, Derek J. Fiterman, Cielo Monterrosa, Asher Begleiter

Original Article

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut

Heleen A. Bardelmeijer, Mariët Ouwehand, Mirte M. Malingré, Jan H. Schellens, Jos H. Beijnen, Olaf van Tellingen

Original Article

Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma

Georg Hempel, Silke Flege, Gudrun Würthwein, Joachim Boos

Original Article

Drug resistance in malignant rhabdoid tumor cell lines

Gary B. Rosson, Timothy S. Vincent, Betty W. Oswald, Cynthia F. Wright

Original Article

PEG-asparaginase (Oncaspar) 2500 U/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols

Hans-Joachim Müller, Rita Beier, João da Palma, Claudia Lanvers, Elvira Ahlke, Volker von Schütz, Martin Gunkel, Alexander Horn, Martin Schrappe, Günter Henze, Karen Kranz, Joachim Boos

Original Article

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

Hideki Ueno, Shuichi Okada, Takuji Okusaka, Masafumi Ikeda, Hitoshi Kuriyama

Original Article

Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells

Minori Saitoh, Katsunari Taguchi, Kazuhiro Momose, Kazutaka Suga, Noriyuki Yamazaki, Chizuko Ono, Tatsuo Suzuki, Osamu Takeuchi, Shuhei Yasuda, Keiji Miyata

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine